Abgenix Appoints H. Ward Wolff as Chief Financial Officer

09-Sep-2004

Abgenix, Inc. (Nasdaq:ABGX) today announced the appointment of H. Ward Wolff as Chief Financial Officer and Senior Vice President, Finance, effective September 13.

"Ward brings over 25 years of finance, operating and management experience to Abgenix at an important time in our corporate evolution as we seek to develop and commercialize a diverse pipeline of novel antibody therapeutics for a variety of unmet medical needs," said Bill Ringo, CEO and President of Abgenix. "His impressive range of experience assisting companies to develop successful financial and capital market strategies will help Abgenix progress through this next phase of growth and development."

Prior to joining Abgenix, Mr. Wolff served as Chief Financial Officer of QuantumShift, Inc., a provider of telecommunications management services. From 1998 to 2002, he was Senior Vice President and Chief Financial Officer of DoubleTwist, Inc., a life sciences company integrating genomic information and bioinformatics analysis tools for the pharmaceutical and biotechnology industries and research institutions.

From 1992 to 1998, Mr. Wolff was Senior Vice President of Finance and Administration and Chief Financial Officer of Premenos Technology Corporation, a provider of electronic commerce software and services, during which time the company completed its initial public offering of common stock. Previously, he served as an Executive Director of Russell Reynolds Associates, Inc., an international management recruiting firm, and held a number of positions with Price Waterhouse as a certified public accountant, including Senior Audit Manager.

Mr. Wolff received a B.A. in Economics from the University of California at Berkeley and an M.B.A. from Harvard Business School.

https://www.bionity.com/en/news/39509/abgenix-appoints-h-ward-wolff-as-chief-financial-officer.html